Delivery Order SPE2DB22D1106-SPE2DB25FDTC3

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,047.50, is a delivery order for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,139.50, is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025 and is a Firm Fixed Price Delivery Order. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,218.16, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of October 22, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This federal contract award, valued at $3,710.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $2,457.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of December 24, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not associated with a set-aside program and is an open competition...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,276.00, is for the delivery of 4566771267 WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract is a firm fixed-price delivery order with a completion date of December 20, 2024. No set-aside designation was used for this award. AmerisourceBergen also holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,923.68, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The firm-fixed-price Delivery Order contract, valued at $2,457.00, has an ultimate completion date of December 24, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order valued at $3,197.52 for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This contract award, valued at $12,104.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication, with a completion date of November 14, 2024. The contract is a Firm Fixed Price Delivery Order, and no set-aside requirements were used. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTC3
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,866.50, is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 4/4/25, 10:04 AM